This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Making Antimicrobial Stewardship a Priority: Integrating Evidence-Based Practices and Guidelines to Improve Antimicrobial Use

Making Antimicrobial Stewardship a Priority: Integrating Evidence-Based Practices and Guidelines to Improve Antimicrobial Use

Format

Slide Lecture Series

Time to Complete

1.50 hours

Released

May 22, 2017

Expires

May 22, 2018
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM

Pharmacy Credits

Pharmacists may earn 1.50 CPE Credits (0.15 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website and need to register/log in on the ASHP site). Your certificate will save on ASHP.org and will not be included in your myCME CME History.

Accredited Provider

This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Merck

Program Description

The National Action Plan for Combating Antibiotic-Resistant Bacteria, released by the White House in March 2015, highlighted the urgent need to slow the emergence of resistant bacteria and spread of resistant infections. Since that time, key collaborators within government and non-government organizations have responded with initiatives directly focused on improving antimicrobial stewardship programs (ASPs). These include new antibiotic stewardship guidelines jointly published by the Infectious Diseases Society of America and Society for Healthcare Epidemiology of America, an Antibiotic Stewardship Playbook published by the National Quality Forum, and Core Elements of Hospital Antibiotic Stewardship Programs published by the Centers for Disease Control and Prevention. Pharmacists and physicians at the front lines of antimicrobial stewardship need to stay up to date on this fast evolving landscape and learn strategies to use best-practices to develop and establish ASP priorities and resources in their healthcare setting.

This educational activity will provide a state-of-the-art update on national initiatives that are directly influencing the role of ASPs. Using real-life examples, the faculty will discuss how to best use these resources to optimize ASPs and patient care. Examples will include case scenarios in managing patients with sepsis and Clostridium difficile.

Intended Audience

This continuing education activity was planned to meet the needs of pharmacists and physicians in a variety of practice settings, including large and small healthcare settings, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, physicians, clinical specialists, managers, leaders, and educators who are interested in antimicrobial stewardship programs.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Analyze National initiatives and Guidelines that are directly influencing the role of Antimicrobial Stewardship Programs (ASPs)
  • Select specific clinical areas that ASPs are useful for combating antimicrobial resistance and decreasing the spread of resistant infections
  • Predict the future of antimicrobial stewardship and how national initiatives and standards will influence ASPs

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (eg, employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

Faculty

Kevin W. Garey, PharmD, MS, FASHP (Activity Chair)
Professor and Chair
Department of Clinical Sciences and Administration
University of Houston College of Pharmacy
Houston, TX

Dr. Garey declares he received a research grant from Merck.

Edward J. Septimus, MD, FACP, FIDSA, FSHEA
Medical Director, Infection Prevention and Epidemiology
Clinical Services Group HCA Healthcare System
Professor, Internal Medicine
Texas A&M Health Science Center College of Medicine
Houston, TX

Dr. Septimus reported no financial relationships or relationships to products or devices he or his spouses/life partners have with commercial interests related to the content of this CME activity.

Planners' and Managers' Disclosures

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue